Rhabdomyolysis News and Research

RSS
Rhabdomyolysis (often shortened to simply "rhabdo") is the rapid breakdown (''lysis'') of skeletal muscle (''rhabdomyo'') due to injury to muscle tissue.
Burns and electrocution risk increased with generic phone chargers, says review

Burns and electrocution risk increased with generic phone chargers, says review

Researchers identify previously unknown autoimmune disease involving muscle pain, weakness

Researchers identify previously unknown autoimmune disease involving muscle pain, weakness

Statins associated with low risk of side effects

Statins associated with low risk of side effects

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Testing Service Members for Heat Related Illnesses Before Combat

Testing Service Members for Heat Related Illnesses Before Combat

Tiny 'submarines' could help treat stomach diseases with acid-sensitive drugs

Tiny 'submarines' could help treat stomach diseases with acid-sensitive drugs

Sickle cell trait linked to increased risk of rhabdomyolysis among African American Soldiers

Sickle cell trait linked to increased risk of rhabdomyolysis among African American Soldiers

Sickle cell trait may not increase mortality risk

Sickle cell trait may not increase mortality risk

Study looks at factors that affect physical recovery after participation in ultramarathon

Study looks at factors that affect physical recovery after participation in ultramarathon

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Alzheimer's drug Aricept (donepezil) linked to serious side effects

Alzheimer's drug Aricept (donepezil) linked to serious side effects

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Novartis LDE225 Phase II study for advanced basal cell carcinoma meets primary endpoint

Novartis LDE225 Phase II study for advanced basal cell carcinoma meets primary endpoint